Keryx Biopharma (KERX) Misses Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts KERX Hot Sheet
Price: $3.36 --0%
Financial Fact:
Basic and diluted net loss per common share: -0.39
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Basic and diluted net loss per common share: -0.39
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Keryx Biopharma (NASDAQ: KERX) reported Q3 EPS of ($0.38), $0.11 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $256 thousand versus the consensus estimate of $150 thousand.
For earnings history and earnings-related data on Keryx Biopharma (KERX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Benchmark Reiterates Buy Rating on Odysight.AI Inc. (ODYS)
- Is Treasury selloff a major issue for stock market bulls?
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
